WO2025169089 - OPHTHALMIC COMPOSITIONS OF TYROSINE KINASE INHIBITORS AND THEIR USES
National phase entry is expected:
Publication Number
WO/2025/169089
Publication Date
14.08.2025
International Application No.
PCT/IB2025/051225
International Filing Date
05.02.2025
Title **
[English]
OPHTHALMIC COMPOSITIONS OF TYROSINE KINASE INHIBITORS AND THEIR USES
[French]
COMPOSITIONS OPHTALMIQUES D'INHIBITEURS DE TYROSINE KINASE ET LEURS UTILISATIONS
Applicants **
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Inventors
KHOPADE, Ajay Jaysingh
HALDER, Arindam
PATEL, Vivek
MUNDARGI, Raghavendra
Priority Data
202421007739
05.02.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4549 | |
| EPO | Filing, Examination, Granting | 75734 | |
| Japan | Filing, Examination, Granting | 4442 | |
| South Korea | Filing, Examination, Granting | 6523 | |
| USA | Filing, Examination, Granting | 18940 |
Total:
110,188
Contact Us
Abstract[English]
value of the active pharmaceutical ingredient.[French]
de l'ingrédient pharmaceutique actif.